Immunocore Holdings Ltd (IMCR)

Immunocore Holdings Ltd (IMCR) is a Biotechnology company in the Healthcare sector listed on the NASDAQ.

As of Oct 23, 2026: market cap $1.5B; returns 1 day -3.5%, 1 week +5.4%, 1 year -2.0%.

Immunocore Holdings plc (IMCR) is a commercial-stage biotechnology company headquartered in Oxfordshire, UK, pioneering the development of novel T cell receptor (TCR) bispecific immunotherapies, known as ImmTAC (Immune mobilizing monoclonal TCRs Against Cancer) and ImmTAX molecules.

Groups IMCR belongs to

• Biotechnology
• Immunotherapy
• Commercial Stage Biotech
• United Kingdom Companies
• Bispecific Antibodies
• Healthcare
• Oncology
• Life Sciences
• Biopharmaceutical
• Pharmaceuticals
• Cancer Therapeutics
• Clinical Stage Biopharma
• Monoclonal Antibodies

IMCR financial model: income statement, cash flow and balance sheet